Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digitalis in chronic renal insufficiency.

M Rambausek, E Ritz

    Blood Purification
    |January 1, 1985
    PubMed
    Summary

    Digitalis therapy is complex in renal failure due to altered drug handling and cardiac effects. Digitoxin is often preferred by nephrologists due to its stability despite altered pharmacokinetics in uremia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    De novo glomerulonephritis in patients during remission from Wegener's granulomatosis.

    Clinical nephrology·1992
    Same author

    Reduced capillary density in the myocardium of uremic rats--a stereological study.

    Kidney international·1992
    Same author

    Renal histology in polycystic kidney disease with incipient and advanced renal failure.

    Kidney international·1992
    Same author

    The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease.

    Journal of the American Society of Nephrology : JASN·1992
    Same author

    Severe hemorrhagic complications from infection with nephropathia epidemica strain of Hantavirus.

    Clinical nephrology·1992
    Same author

    Disturbed calcium metabolism in renal failure--pathogenesis and therapeutic strategies.

    Kidney international. Supplement·1992

    Area of Science:

    • Nephrology
    • Cardiology
    • Clinical Pharmacology

    Background:

    • Cardiac dysfunction is prevalent in end-stage renal disease.
    • The use of digitalis glycosides in uremic patients lacks a clear consensus.
    • Potential mechanisms for cardiac dysfunction include toxic factors and altered catecholamine response.

    Purpose of the Study:

    • To review the challenges and considerations for digitalis therapy in patients with renal failure.
    • To discuss the altered pharmacokinetics and pharmacodynamics of digitalis glycosides in uremia.
    • To evaluate the rationale behind the choice of specific digitalis preparations in this population.

    Main Methods:

    • Review of existing literature on digitalis use in renal failure.
    • Analysis of pharmacokinetic and pharmacodynamic alterations of digitalis glycosides.
    • Comparison of different digitalis preparations regarding their suitability for uremic patients.

    Main Results:

    • Uremia significantly alters the pharmacokinetics of some digitalis glycosides, prolonging elimination half-lives of strophanthin and digoxin.
    • Digitoxin's elimination half-life remains largely unchanged in uremia.
    • Altered protein binding and volume of distribution affect digitalis disposition in renal failure.

    Conclusions:

    • Digitalis therapy requires careful consideration in patients with terminal renal failure.
    • Digitoxin is frequently favored by nephrologists due to its pharmacokinetic stability in the context of renal impairment.
    • Understanding altered drug metabolism and distribution is crucial for safe and effective digitalis use in uremia.

    Related Experiment Videos